Literature DB >> 31811351

The effects of nicotinamide on reinstatement to cocaine seeking in male and female Sprague Dawley rats.

Emily A Witt1, Kathryn J Reissner2.   

Abstract

RATIONALE: Interventions for psychostimulant use disorders are of significant need. Nicotinamide (NAM) is a small molecule that can oppose cellular adaptations observed following cocaine exposure in the rodent self-administration and reinstatement model of addiction. In addition, utility of NAM against symptoms of withdrawal and vulnerability to relapse to cocaine use has been suggested by case studies and anecdotal reports. However, the empirical effects of NAM on drug-seeking behaviors have not been examined.
OBJECTIVE: The objective of the current study was to investigate the effects of systemic NAM administration on reinstatement to cocaine seeking, using the rat self-administration/extinction/reinstatement model of cocaine addiction.
METHODS: Male and female Sprague Dawley rats were trained to self-administer i.v. cocaine or food pellets for 2 hrs per day for 12 days, followed by 14-17 days of extinction, during which i.p. NAM injections (0-120 mg/kg) were given 30 minutes prior to each extinction or reinstatement session. Rats were tested on cue-, cocaine-, or food-primed reinstatement, as well as locomotor activity.
RESULTS: Chronic NAM administered throughout extinction dose dependently attenuated cue-primed reinstatement in male rats, but not female rats. In contrast, acute NAM given once prior to reinstatement had no effect on reinstatement. Chronic NAM had no effect on locomotor activity or reinstatement to food seeking.
CONCLUSIONS: The specificity of NAM against cue-primed reinstatement indicates that NAM may influence responsiveness to drug-associated cues, specifically in males. Future studies will examine the mechanism(s) by which NAM may exert this effect.

Entities:  

Keywords:  Cocaine; NAD/NADH; Nicotinamide; PARP-1; Reinstatement; Sex differences

Mesh:

Substances:

Year:  2019        PMID: 31811351      PMCID: PMC7039762          DOI: 10.1007/s00213-019-05404-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  65 in total

Review 1.  Neural substrates of cocaine-cue associations that trigger relapse.

Authors:  Ronald E See
Journal:  Eur J Pharmacol       Date:  2005-10-25       Impact factor: 4.432

2.  Ex vivo protective effects of nicotinamide and 3-aminobenzamide on rat synaptosomes treated with Aβ(1-42).

Authors:  Ezgi Turunc Bayrakdar; Guliz Armagan; Yigit Uyanikgil; Lutfiye Kanit; Ersin Koylu; Ayfer Yalcin
Journal:  Cell Biochem Funct       Date:  2014-08-08       Impact factor: 3.685

3.  Tryptophan-nicotinamide combination in depression.

Authors:  G Chouinard; S N Young; L Annable; T L Sourkes
Journal:  Lancet       Date:  1977-01-29       Impact factor: 79.321

4.  A comparison of the effects of nicotinamide and progesterone on functional recovery of cognitive behavior following cortical contusion injury in the rat.

Authors:  Todd C Peterson; Gail D Anderson; Eric D Kantor; Michael R Hoane
Journal:  J Neurotrauma       Date:  2012-11-27       Impact factor: 5.269

5.  Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau.

Authors:  Kim N Green; Joan S Steffan; Hilda Martinez-Coria; Xuemin Sun; Steven S Schreiber; Leslie Michels Thompson; Frank M LaFerla
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

6.  Working memory and salivary brain-derived neurotrophic factor as developmental predictors of cocaine seeking in male and female rats.

Authors:  Chloe J Jordan; Susan L Andersen
Journal:  Addict Biol       Date:  2017-08-31       Impact factor: 4.280

7.  Zinc inhibits astrocyte glutamate uptake by activation of poly(ADP-ribose) polymerase-1.

Authors:  Sang Won Suh; Koji Aoyama; Conrad C Alano; Christopher M Anderson; Aaron M Hamby; Raymond A Swanson
Journal:  Mol Med       Date:  2007 Jul-Aug       Impact factor: 6.354

8.  Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats.

Authors:  Mykhailo M Guzyk; Artem A Tykhomyrov; Victor S Nedzvetsky; Irina V Prischepa; Tatiana V Grinenko; Lesya V Yanitska; Tamara M Kuchmerovska
Journal:  Neurochem Res       Date:  2016-06-02       Impact factor: 3.996

9.  Pharmacokinetics and biochemistry studies on nicotinamide in the mouse.

Authors:  M R Stratford; M F Dennis
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 10.  The role of PARP in DNA repair and its therapeutic exploitation.

Authors:  M Javle; N J Curtin
Journal:  Br J Cancer       Date:  2011-10-11       Impact factor: 7.640

View more
  3 in total

1.  Nicotinamide Adenine Dinucleotide (NAD+) and Enkephalinase Inhibition (IV1114589NAD) Infusions Significantly Attenuate Psychiatric Burden Sequalae in Substance Use Disorder (SUD) in Fifty Cases.

Authors:  Kenneth Blum; David Han; David Baron; Shan Kazmi; Igor Elman; Luis Llanos Gomez; Marjorie C Gondre-Lewis; Panyotis K Thanos; Eric R Braverman; Rajendra D Badgaiyan
Journal:  Curr Psychiatry Res Rev       Date:  2022-06-21

2.  Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?

Authors:  Kenneth Blum; Ali Raza; Tiffany Schultz; Rehan Jalali; Richard Green; Raymond Brewer; Panyotis K Thanos; Thomas McLaughlin; David Baron; Abdalla Bowirrat; Igor Elman; B William Downs; Debasis Bagchi; Rajendra D Badgaiyan
Journal:  Acta Sci Neurol       Date:  2021-02-02

Review 3.  A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration.

Authors:  Kenneth Blum; Shan Kazmi; Edward J Modestino; Bill William Downs; Debasis Bagchi; David Baron; Thomas McLaughlin; Richard Green; Rehan Jalali; Panayotis K Thanos; Igor Elman; Rajendra D Badgaiyan; Abdalla Bowirrat; Mark S Gold
Journal:  J Pers Med       Date:  2021-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.